Skip to main content

Table 4 The hematological parameters of TH-treated groups compared to controls

From: The anti-cancer effects of Tualang honey in modulating breast carcinogenesis: an experimental animal study

 

Groups

 
 

0

Normal control

1

-ve control

2

(0.2 g/kg TH)

3

(1.0 g/kg TH)

4

(2.0 g/kg TH)

p valuea

RBC (1012/L)

7.15 (0.27)

6.35 (0.75)

7.35 (1.22)

7.4 (1.025)

6.85 (1.67)

0.088

Hb (g/dl)

15.35 (0.62)

14.1 (1.62)

14.8 (1.92)

15 (1.97)

15.25 (2.77)

0.062

PCV (%)

48 (2.5)

42 (3.25)

48.5 (5)

48.5 (9)

47.5 (8.75)

0.047

MCV (fl)

65.5 (1.5)

66 (4.75)

65.5 (6.75)

66 (1.75)

65.5 (3.75)

0.004

MCH (pg)

21 (2)

21.5 (1.5)

20.5 (2.25)

21 (2.25)

21.5 (2)

0.958

MCHC (g/L)

32.5 (1)

31.5 (1.75)

31 (1.5)

31 (2.5)

32 (3)

0.000

RDW (%)

11.85 (1.7)

13.85 (1.7)

12.25 (2.725)

12.6 (1.5)

12.9 (2.22)

0.010

TWBC (109/L)

4.85 (1.75)

6.14 (8.72)

5.05 (2.4)

4.95 (6)

6.25 (5.7)

0.178

Polymorphs (%)

33 (9.5)

42 (19.75)

34 (16.5)

32 (12)

32.5 (13.5)

0.009

Lymphocytes (%)

66 (5.5)

54 (20.75)

65 (13.5)

64.5 (13.5)

66.5 (15)

0.010

Monocytes (%)

1.5 (1.5)

1.5 (2.5)

1.25 (1)

1 (0)

1 (2)

0.649

Eosinophils (%)

0 (1.25)

0 (1.25)

0

0 (2)

0.5 (1)

0.534

Basophils (%)

0

0

0

0

0

1.000

Platelets’ (109/L)

809.5 (149)

627.5 (196.75)

734 (197)

758.5 (178)

710 (89.5)

0.042

  1. aKruskal-Wallis test. Data are expressed as median interquartile range (IqR). Values are statistically significant at p ≤ 0.05. Legends: TH = Tualang honey, −ve = Negative (group received tumor induction but no honey treatment)